Search results for "ANTIFUNGAL"

showing 10 items of 348 documents

Assessment of antifungal activity of extracts from nettle (Urtica dioica L.) against Alternaria solani = Ocena aktywności przeciwgrzybowej ekstraktów…

2015

(Urtica dioica L.) w stężeniach 2,5, 5,0, 10,0, 20,0, 40,0% wobec fitopatogennego szczepu Alternaria solani. Aktywność przeciwgrzybową ekstraktów z pokrzywy określono w oparciu o indeks tempa wzrostu grzybni oraz indeks kiełkowania zarodników. W badaniach określono również wpływ metod sterylizacji testowanych wyciągów na ich aktywność. Na podstawie uzyskanych wyników wykazano, iż ekstrakty sterylizowane parą wodną pod ciśnieniem nie wykazują aktywności przeciwgrzybowej. W przypadku ekstraktu z korzenia, który charakteryzował się większą aktywnością inhibicyjną, uzyskano zaledwie 7% redukcję tempa wzrostu grzybni. Natomiast ekstrakt z korzenia poddany sterylizacji przez sączenie ograniczał o…

indeks kiełkowania zarodnikówaktywność przeciwgrzybowaspores germination indexantifungal activityindeks tempa wzrostuUrtica dioicaAlternaria solanigrowth rate indexProceedings of ECOpole
researchProduct

A challenging case of chorioretinitis and skin lesions in a lung transplant recipient

2018

no

infection and infectious agentsmedicine.medical_specialtyinfectious diseaseclinical research/practicecomplication: infectioulung transplantation/pulmonologyBiopsymedicineImmunology and AllergybiopsyPharmacology (medical)Lung transplant recipientTransplantationmedicine.diagnostic_testinfection and infectious agentbusiness.industryChorioretinitisantibiotic: antifungalmedicine.diseaseinfection and infectious agents - fungalDermatologycomplication: infectiousAntibiotics antifungalInfectious disease (medical specialty)Skin lesionbusinessantibiotic: antifungal; biopsy; clinical research/practice; complication: infectious; infection and infectious agents; infection and infectious agents - fungal; infectious disease; lung transplantation/pulmonology; Immunology and Allergy; Transplantation; Pharmacology (medical)American Journal of Transplantation
researchProduct

The Influence of Chemical Composition of Commercial Lemon Essential Oils on the Growth of Candida Strains

2013

Candida yeasts are saprophytes naturally present in the environment and forming colonies on human mucous membranes and skin. They are opportunistic fungi that cause severe and even fatal infections in immunocompromised individuals. Several essential oils, including eucalyptus, pine, cinnamon and lemon, have been shown to be effective against Candida strains. This study addresses the chemical composition of some commercial lemon essential oils and their antifungal potential against selected Candida yeast strains. Antifungal potential and minimum inhibitory concentrations were determined for six commercial lemon essential oils against five Candida yeast strains (Candida albicans 31, Candida t…

lemon essential oilsAntifungal AgentsVeterinary (miscellaneous)Microbial Sensitivity TestsPlant ScienceBiologyApplied Microbiology and BiotechnologyMicrobiologyGas Chromatography-Mass SpectrometryArticleMicrobiologyTerpeneCandida tropicalisMicrobial ecologyCandida albicansOils VolatilePlant OilsCandida albicansChemical compositionCandidaCandida glabratabiology.organism_classificationYeastCorpus albicansveterinary (miscalleneous)MonoterpenesGCMSAgronomy and Crop ScienceantifungalMycopathologia
researchProduct

Non-wild-type cryptococcosis in a child with multivisceral organ transplant who owned bird pets.

2020

Cryptococcosis is the third most common invasive fungal infection in solid-organ transplant recipients, although it is rarely reported in transplanted children. It typically appears as a late-onset infection with central nervous system or pulmonary involvement. We present a case of cryptococcosis caused by a non-wild strain in a 10-year-old child who owned two pet birds, and review the existent literature.

medicine.medical_specialtyAntifungal AgentsCentral nervous systemDrug resistance030230 surgeryOrgan transplantationBirds03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansChildCryptococcus neoformansTransplantationNon wild typebiologybusiness.industryCryptococcosisOrgan TransplantationPetsbiology.organism_classificationmedicine.diseaseInfectious Diseasesmedicine.anatomical_structureImmunologyCryptococcosisCryptococcus neoformans030211 gastroenterology & hepatologySolid organ transplantationbusinessTransplant infectious disease : an official journal of the Transplantation SocietyREFERENCES
researchProduct

Current Concepts in Therapy of Chronic Rhinosinusitis and Nasal Polyposis

2004

The exact pathophysiological mechanisms leading to chronic rhinosinusitis (CRS) still to a large extent remain obscure. However, recently there has been some progress in elucidating the etiology of nasal polyposis, especially regarding tissue eosinophilia as well as the role of aspirin intolerance and eicosanoid mediators. Endonasal sinus surgery has evolved to be the treatment of choice in CRS and nasal polyposis in all cases where conservative treatment has failed or resulted in only a partial or temporary relief. Today, state of the art in surgical technique includes the ability to combine microscopic and endoscopic procedures. Regardless of technical advances like powered instrumentatio…

medicine.medical_specialtyAntifungal AgentsChronic rhinosinusitisNasal PolypsPostoperative ComplicationsEosinophiliaParanasal Sinusesotorhinolaryngologic diseasesmedicineHumansEosinophiliaNasal polypsSinusitisSinusitisRhinitisAspirinmedicine.diagnostic_testbusiness.industryEndoscopyrespiratory systemmedicine.diseaseAnti-Bacterial AgentsEndoscopySurgeryConservative treatmentTreatment OutcomeSurgery Computer-AssistedOtorhinolaryngologyChronic DiseaseHistamine H1 AntagonistsEtiologySteroidsASPIRIN INTOLERANCEmedicine.symptombusinessORL
researchProduct

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital se…

2007

As antifungal agents are frequently used in hematology and oncology, economic data on the empirical therapy of suspected systemic fungal infection are pivotal. Data were analyzed according to: (1) the rate of nephrotoxicity related to treatment with caspofungin in comparison to liposomal amphotericin B (L-AmB) from a randomized clinical trial, (2) the effect of nephrotoxicity on length of hospital stay from a European observational study, and (3) an example of total bottom-up cost in a department of hematology in Germany. All estimates include 95% confidence intervals (CI) using two-stage Monte Carlo simulation on binominal and Gaussian random variables from separate studies with comparable…

medicine.medical_specialtyAntifungal AgentsLiposomal amphotericin Blaw.inventionNephrotoxicitychemistry.chemical_compoundEchinocandinsLipopeptidesRandomized controlled trialDouble-Blind MethodlawCaspofunginBottom-up studyAmphotericin BInternal medicineAmphotericin BGermanymedicineHumansLongitudinal StudiesProspective StudiesProspective cohort studyIntensive care medicineNephrotoxicitybusiness.industryGeneral MedicineHematologybacterial infections and mycosesConfidence intervalEconomic evaluationchemistryMycosesLiposomesNumber needed to treatCosts and Cost AnalysisObservational studyOriginal ArticleCaspofunginbusinessmedicine.drugAnnals of Hematology
researchProduct

Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B

1996

An important determinant of nephrotoxicity, which is the major complication of long-term amphotericin B treatment, is dysfunction of distal tubular epithelial cells. The underlying cause for this rather selective damage to the cells is unknown. In the present investigation, it was shown that kidney epithelial cells were initially damaged by amphotericin B at concentrations of 2.5 to 10 micrograms/ml, as demonstrable by a dramatic drop in cellular K+ levels. Cells could recover from the initial toxic action of the polyene if they were kept in medium of neutral pH, and cellular K+ levels returned to normal after 6 h. However, the recovery mechanisms failed at lower pHs of 5.6 to 6.0. At low p…

medicine.medical_specialtyAntifungal AgentsLumen (anatomy)PharmacologyBiologyEpitheliumCell LineNephrotoxicitychemistry.chemical_compoundAdenosine TriphosphateAmphotericin BInternal medicineAmphotericin BLactate dehydrogenasemedicineAnimalsPharmacology (medical)Kidney Tubules DistalPharmacologyKidneyL-Lactate DehydrogenaseHydrogen-Ion ConcentrationMacaca mulattaIn vitroEpitheliumInfectious Diseasesmedicine.anatomical_structureEndocrinologychemistryToxicityPotassiumResearch Articlemedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Fungal Necrotizing Scleritis After Intravitreal Injection Therapy

2020

PURPOSE To report a case of infectious necrotizing scleritis secondary to Aspergillus terreus after intravitreal injection therapy. METHODS This is a case report with literature review. RESULTS A 98-year-old woman receiving intravitreal aflibercept injections for neovascular age-related macular degeneration in the left eye presented with severe pain, redness, and purulent discharge at the injection site. She was initially treated with topical fortified antibiotics, and clinical improvement was achieved, although microbial cultures showed negative results. Two months later, she presented with severe ocular pain and was diagnosed with anterior necrotizing scleritis. Scleral scrapings were col…

medicine.medical_specialtyAntifungal Agentsmedicine.drug_classRecombinant Fusion ProteinsAntibioticsAngiogenesis InhibitorsmedicineAspergillosisHumansAspergillus terreusNecrotizing scleritisAfliberceptAged 80 and overVoriconazolebiologybusiness.industryInjection therapyMacular degenerationmedicine.diseasebiology.organism_classificationSurgeryOphthalmologyAspergillusReceptors Vascular Endothelial Growth FactorAcute DiseaseIntravitreal InjectionsWet Macular DegenerationEtiologyFemalebusinessEye Infections FungalScleraScleritismedicine.drugCornea
researchProduct

The paradox of the evidence about invasive fungal infections prevention

2016

Invasive fungal infections (IFIs) are characterized by high morbidity and mortality in non-neutropenic critically ill patients. Attributable mortality due to Candida spp. infections ranges from about 42 to 63 % [1, 2]. Data from large observational and retrospective studies show an association between early antifungal treatment and improved survival [3, 4]. Updated clinical practice guidelines for the management of candidiasis have been recently published [5]. In 2006, Playford et al. published a Cochrane systematic review investigating the use of antifungal agents for prevention of IFIs in non-neutropenic critically ill patients [6]. In that review, the outcome of proven IFI was defined as…

medicine.medical_specialtyPediatricsAntifungal AgentsUrinary systemMEDLINECritical Care and Intensive Care Medicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineAntifungal AgentHumansInfection controlInvasive Fungal Infection030212 general & internal medicinebusiness.industryAntifungal Agents; Humans; Invasive Fungal Infections; Critical Care and Intensive Care Medicine030208 emergency & critical care medicineRetrospective cohort studyFungal EsophagitisEditorialmedicine.anatomical_structureObservational studybusinessInvasive Fungal InfectionsHumanRespiratory tractCritical Care
researchProduct

How to manage aspergillosis in non-neutropenic intensive care unit patients.

2014

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level …

medicine.medical_specialtyPediatricsChronic ObstructiveAntifungal AgentsCritical IllnessPopulationPulmonary diseaseSettore MED/41 - AnestesiologiaReviewNeutropeniaOpportunistic InfectionsAspergillosisCritical Care and Intensive Care MedicineCommunicable DiseasesCommunicable Diseases Emerginglaw.inventionPulmonary DiseaseImmunocompromised HostPulmonary Disease Chronic ObstructiveAspergillosis non-neutropenic ICUlawAdrenal Cortex HormonesRisk FactorsEpidemiologymedicinenon-neutropenicPrevalenceAspergillosisHumansIntensive care medicineeducationEmergingeducation.field_of_studybusiness.industryIncidence (epidemiology)Medicine (all)IncidenceAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicinemedicine.diseasePrognosisIntensive care unitAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised HostIntensive Care UnitsCohortICUAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicine; Medicine (all)businesssepsis aspergillosis icu managementCritical care (London, England)
researchProduct